Search Results
Jan 06, 2026, 12:00 ET OneStream Enters into Definitive Agreement to be Acquired by Hg for $6.4 Billion
the transaction is not completed; (vi) the diversion of OneStream management's time and attention from ongoing business operations and opportunities; (vii) the response of competitors and other market participants to the transaction; (viii) potential litigation relating to the transaction; (ix) uncertainty
More news about: OneStream, Inc.
Jan 05, 2026, 08:45 ET FIBRA PROLOGIS ANNOUNCES SENIOR LEADERSHIP TRANSITION
trust ("FIBRA") status and tax structuring, (vi) availability of financing and capital, the levels of debt that we maintain and our credit ratings, (vii) risks related to our investments (viii) environmental uncertainties, including risks of natural disasters, (ix) risks related to the coronavirus pandemic,
More news about: FIBRA Prologis
Jan 05, 2026, 08:45 ET FIBRA PROLOGIS ANUNCIA TRANSICIÓN EN LA ALTA DIRECCIÓN
inversión en bienes raíces, (vi) la disponibilidad de financiamiento y capital, los niveles de endeudamiento que mantengamos y nuestras calificaciones, (vii) los riesgos relacionados con nuestras inversiones, (viii) incertidumbres ambientales, incluyendo los riesgos de desastres naturales, (ix) riesgos relacionados
More news about: FIBRA Prologis
Jan 05, 2026, 08:45 ET FIBRA PROLOGIS ANUNCIA TRANSICIÓN EN LA ALTA DIRECCIÓN
inversión en bienes raíces, (vi) la disponibilidad de financiamiento y capital, los niveles de endeudamiento que mantengamos y nuestras calificaciones, (vii) los riesgos relacionados con nuestras inversiones, (viii) incertidumbres ambientales, incluyendo los riesgos de desastres naturales, (ix) riesgos relacionados
More news about: FIBRA Prologis
Jan 05, 2026, 07:00 ET RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects
ability to successfully commercialize and promote Talicia®; (vi) the Company's ability to establish and maintain corporate collaborations; (vii) the Company's ability to acquire products approved for marketing in the U.S. that achieve commercial success and build its own marketing and commercialization
More news about: RedHill Biopharma Ltd.
Jan 02, 2026, 16:30 ET Highland Opportunities and Income Fund Announces the Regular Monthly Distribution
increased competition; (iv) increases in property taxes and operating expenses; (v) changes in zoning laws; (vi) casualty and condemnation losses; (vii) variations in rental income, neighborhood values or the appeal of property to tenants; (viii) the availability of financing and (ix) changes in interest
More news about: Highland Opportunities and Income Fund
Dec 29, 2025, 10:00 ET Scott+Scott Attorneys at Law LLP Announce Notice of Pendency and Proposed Settlement of Stockholder Class Action for All Members of the Class Consisting of All Record and Beneficial Holders of Power & Digital Infrastructure Acquisition Corp, ("XPDI" OR The"Company") Class A Common Stock Who Held Such Stock Between January 14, 2022 and January 20, 2022
Plaintiff's Counsel out of the Settlement Fund and whether and in what amount any service award to Plaintiff should be paid out of the Fee and Expense Award; (vii) hear and rule on any objections to the Settlement, the Plan of Allocation, or Plaintiff's Counsel's application for an award of attorneys' fees and
More news about: Scott+Scott Attorneys at Law LLP
Dec 29, 2025, 06:15 ET Brand Engagement Network Finalizes Agreement for a Proprietary AI Engagement Solution with a Leading Global Ad Agency for One of the World's Top Pharmaceutical Companies
ability to retain and expand our relationships with existing customers; (vi) our dependence on our senior management team and other key employees; (vii) risks associated with downturns in the economy and reductions in advertising and marketing spend; (viii) risks associated with our presence in the emerging
More news about: Brand Engagement Network, Inc. (BEN)
Dec 25, 2025, 03:45 ET China's First Domestic Anti-CTLA-4 Monoclonal Antibody, Innovent's TABOSUN® (Ipilimumab N01 Injection) Received NMPA Approval
4:2-9. doi:10.1634/theoncologist.13-S4-2vii. Wang J, et al. Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefit. mAbs 2019;11(8): 1443-1451. doi:10.1080/19420862.2019.1654303
More news about: Innovent Biologics
Dec 24, 2025, 07:00 ET Cloopen Announces Receipt of Preliminary Non-Binding "Going Private" Proposal
letter (the "Proposal"), dated December 22, 2025, from Mr. Changxun Sun, the Company's founder and chief executive officer, and Trustbridge Partners VII, L.P. (collectively, the "Buyer Group"), proposing to acquire all of the outstanding Class A ordinary shares and Class B ordinary shares of the Company
More news about: Cloopen Group Holding Limited
Dec 23, 2025, 08:45 ET TrueCar Stockholders Approve Transaction with Fair Holdings
relationships, operating results and business generally; (vi) the risk that the pending transaction disrupts TrueCar's current plans and operations; (vii) TrueCar's ability to retain and hire key personnel and maintain relationships with key business partners and customers, and others with whom it does
More news about: TrueCar, Inc.
Dec 22, 2025, 13:21 ET Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach
biosecurity industry, including due to advancements in technology, emerging competition and evolution in industry demands, standards and regulations, (vii) the outcome of any pending or potential legal proceedings against Ginkgo, (viii) our ability to realize the expected benefits from and the success of
More news about: Ginkgo Bioworks
Dec 22, 2025, 10:00 ET Grant & Eisenhofer P.A. Announce Notice of Pendency and Proposed Settlement of Stockholder Class Action For All Record and Beneficial Holders of DMY II Class A Common Stock Held Between March 12, 2021 through April 20, 2021
entered; (vi) determine whether the proposed Plan of Allocation of the Net Settlement Fund is fair and reasonable, and should therefore be approved; (vii) determine whether and in what amount any Fee and Expense Award should be paid to Plaintiffs' Counsel out of the Settlement Fund and whether and in what
More news about: Grant & Eisenhofer P.A.
Dec 18, 2025, 08:00 ET Deerpath Capital Closes Seventh Flagship Fund, Exceeding its $2 Billion Equity Target
provider of cash-flow-based senior debt financing to sponsor-backed U.S. lower middle market companies, today announced the closing of Deerpath Fund VII ("Fund VII"). The fund exceeded its $2 billion equity target and, together with anticipated leverage, is expected to support approximately $3.5 billion of total
More news about: Deerpath Capital Management, LP
Dec 17, 2025, 08:00 ET Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment
biosecurity industry, including due to advancements in technology, emerging competition and evolution in industry demands, standards and regulations, (vii) the outcome of any pending or potential legal proceedings against Ginkgo, (viii) our ability to realize the expected benefits from and the success of
More news about: Ginkgo Bioworks
Dec 17, 2025, 07:19 ET Netflix Welcomes Warner Bros. Discovery Board Recommendation
respective directors; (vi) the risk that disruptions from the Merger will harm Netflix's or WBD's business, including current plans and operations; (vii) the ability of Netflix or WBD to retain and hire key personnel; (viii) potential adverse reactions or changes to business relationships resulting from
More news about: Netflix, Inc.
Dec 17, 2025, 07:04 ET Netflix Welcomes Warner Bros. Discovery Board Recommendation
respective directors; (vi) the risk that disruptions from the Merger will harm Netflix's or WBD's business, including current plans and operations; (vii) the ability of Netflix or WBD to retain and hire key personnel; (viii) potential adverse reactions or changes to business relationships resulting from
More news about: Netflix, Inc.
Dec 17, 2025, 06:50 ET Sealed Air Announces Expiration of "Go-Shop" Period
with customers, suppliers, employees, stockholders and other business relationships and on the Company's operating results and business generally; (vii) the risk that the Transaction and its announcement could have adverse effects on the market price of the Company's common stock; (viii) the possibility
More news about: Sealed Air
Dec 17, 2025, 06:45 ET PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
https://www.clinicaltrials.gov/study/NCT04700124. vii Challita-Eid PM, Satpayev D, Yang P, et al. Enfortumab vedotin antibody-drug conjugate targeting nectin-4 is a highly potent therapeutic agent
More news about: Astellas Pharma Inc.
Dec 16, 2025, 18:16 ET FIBRA Prologis Anuncia la Venta de 440,000 Pies Cuadrados
inversión en bienes raíces, (vi) la disponibilidad de financiamiento y capital, los niveles de endeudamiento que mantengamos y nuestras calificaciones, (vii) los riesgos relacionados con nuestras inversiones, (viii) incertidumbres ambientales, incluyendo los riesgos de desastres naturales, (ix) riesgos relacionados
More news about: FIBRA Prologis
Dec 16, 2025, 18:15 ET FIBRA Prologis Anuncia la Venta de 440,000 Pies Cuadrados
inversión en bienes raíces, (vi) la disponibilidad de financiamiento y capital, los niveles de endeudamiento que mantengamos y nuestras calificaciones, (vii) los riesgos relacionados con nuestras inversiones, (viii) incertidumbres ambientales, incluyendo los riesgos de desastres naturales, (ix) riesgos relacionados
More news about: FIBRA Prologis
Dec 16, 2025, 18:07 ET FIBRA Prologis Announces Disposition of 440,000 Square Feet
trust ("FIBRA") status and tax structuring, (vi) availability of financing and capital, the levels of debt that we maintain and our credit ratings, (vii) risks related to our investments (viii) environmental uncertainties, including risks of natural disasters, (ix) risks related to the coronavirus pandemic,
More news about: FIBRA Prologis
Dec 16, 2025, 12:02 ET EQT completes sale of shares in Enity Holding AB (publ)
Shareholder, of which EQT VII received c. SEK 565 million STOCKHOLM, Dec. 16, 2025 /PRNewswire/ -- Butterfly HoldCo Pte. Ltd (the "Main Shareholder"), an affiliate of the EQT VII fund ("EQT VII") is pleased to announce
More news about: EQT
Dec 16, 2025, 08:45 ET Independent Proxy Advisory Firms ISS and Glass Lewis Recommend TrueCar Stockholders Vote "FOR" Pending Transaction with Fair Holdings
relationships, operating results and business generally; (vi) the risk that the pending transaction disrupts TrueCar's current plans and operations; (vii) TrueCar's ability to retain and hire key personnel and maintain relationships with key business partners and customers, and others with whom it does
More news about: TrueCar, Inc.
Dec 16, 2025, 07:30 ET REZOLVE-AA Phase 2b Study of Rezpegaldesleukin Establishes Proof-of-Concept in Patients with Severe-to-Very-Severe Alopecia Areata
drug candidates, patents that have issued may not be enforceable, or additional intellectual property licenses from third parties may be required; and (vii) certain other important risks and uncertainties set forth in our Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on
More news about: Nektar Therapeutics